Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.875 USD | 0.00% | -8.15% | -1.59% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 3.57M | Capitalization | 154M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -125M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 43.1 x |
P/E ratio 2024 * |
-1.02
x | P/E ratio 2025 * |
-1
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.56% |
Latest transcript on Adicet Bio, Inc.
1 week | -8.15% | ||
Current month | -20.85% | ||
1 month | -15.45% | ||
3 months | -24.70% | ||
6 months | +52.46% | ||
Current year | -1.59% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.865 | -0.53% | 233 420 |
24-04-24 | 1.875 | -10.71% | 1,478,484 |
24-04-23 | 2.1 | +5.00% | 1,130,428 |
24-04-22 | 2 | +2.56% | 325,351 |
24-04-19 | 1.95 | -3.70% | 727,751 |
Delayed Quote Nasdaq, April 25, 2024 at 10:48 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.59% | 154M | |
+0.77% | 43.84B | |
+5.20% | 41.68B | |
+45.49% | 41.25B | |
-10.92% | 27.04B | |
+7.32% | 25.53B | |
-25.66% | 18.18B | |
-4.26% | 12.29B | |
+25.40% | 12.29B | |
+6.82% | 11.15B |
- Stock Market
- Equities
- ACET Stock